July 21, 2022
by Basem Goueli, M.D., Ph.D., MBA
Biopharma insight
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
July 20, 2022
by Amandeep Singh
Biopharma insight
The ‘AI in Pharma’ start-up space has been rapidly exploding, with new companies being formed every month. The explosion has …
July 19, 2022
by Natalia Honchar, Andrii Buvailo
Biopharma insight
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
July 18, 2022
by Joseph Pareti
Biopharma insight
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
July 14, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
July 11, 2022
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
June 23, 2022
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
June 17, 2022
by Andrii Buvailo
Biopharma insight
While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving …
June 4, 2022
by Ivan Kondratov
Biopharma insight
Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is …
May 31, 2022
by Chris De Savi
Biopharma insight
The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …